OGEN ORAGENICS INC Product Launches 8-K Filing 2024 - Product Launch Oragenics, Inc. announced the completion of manufacturing for its intranasal device and drug in preparation for a Phase IIa clinical trial targeting concussed patients with its lead candidate, ONP-002.Get access to all SEC 8-K filings of the ORAGENICS INC